Atlas Genetics has appointed Marc Jones as Chief Operating Officer and Chief Financial Officer. He joins from Good Start Genetics, where he served as the COO and CFO. Prior to this, Marc served as the CFO of T2 Biosystems, where he oversaw the company’s successful public offering, raising nearly $100 million in capital, and helped drive the commercialization of the company’s first FDA approved IVD product. Previously, Jonhees held the CFO position at Crashlytics, Ivenix and CHiL Semiconductor. Earlier in his career, he held a number of corporate finance positions ranging from Fortune 50 companies to high-growth startups.
